Italy
· Delayed Price · Currency is EUR Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of EUR 84.52 billion. The enterprise value is 105.51 billion.
| Market Cap | 84.52B |
| Enterprise Value | 105.51B |
Important Dates
The next estimated earnings date is Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | Mar 7, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.90% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 225.89M |
Valuation Ratios
The trailing PE ratio is 14.63.
| PE Ratio | 14.63 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 92.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.94, with an EV/FCF ratio of 24.00.
| EV / Earnings | 18.27 |
| EV / Sales | 0.68 |
| EV / EBITDA | 11.94 |
| EV / EBIT | 13.04 |
| EV / FCF | 24.00 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.45 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | 7.04 |
| Interest Coverage | 7.76 |
Financial Efficiency
Return on equity (ROE) is 14.77% and return on invested capital (ROIC) is 8.28%.
| Return on Equity (ROE) | 14.77% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 8.28% |
| Return on Capital Employed (ROCE) | 12.05% |
| Revenue Per Employee | 1.64M |
| Profits Per Employee | 55,433 |
| Employee Count | 104,200 |
| Asset Turnover | 1.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -14.78% |
| 50-Day Moving Average | 379.65 |
| 200-Day Moving Average | 424.80 |
| Relative Strength Index (RSI) | 62.62 |
| Average Volume (20 Days) | 1 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.59 |
Income Statement
In the last 12 months, Elevance Health had revenue of EUR 170.78 billion and earned 5.78 billion in profits. Earnings per share was 24.80.
| Revenue | 170.78B |
| Gross Profit | 47.56B |
| Operating Income | 8.88B |
| Pretax Income | 7.63B |
| Net Income | 5.78B |
| EBITDA | 9.52B |
| EBIT | 8.88B |
| Earnings Per Share (EPS) | 24.80 |
Balance Sheet
The company has 33.50 billion in cash and 30.95 billion in debt, giving a net cash position of -22.94 billion.
| Cash & Cash Equivalents | 33.50B |
| Total Debt | 30.95B |
| Net Cash | -22.94B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.01B |
| Book Value Per Share | 175.43 |
| Working Capital | 17.73B |
Cash Flow
In the last 12 months, operating cash flow was 5.61 billion and capital expenditures -1.21 billion, giving a free cash flow of 4.40 billion.
| Operating Cash Flow | 5.61B |
| Capital Expenditures | -1.21B |
| Free Cash Flow | 4.40B |
| FCF Per Share | n/a |
Margins
Gross margin is 27.85%, with operating and profit margins of 5.20% and 3.38%.
| Gross Margin | 27.85% |
| Operating Margin | 5.20% |
| Pretax Margin | 4.47% |
| Profit Margin | 3.38% |
| EBITDA Margin | 5.57% |
| EBIT Margin | 5.20% |
| FCF Margin | 2.57% |
Dividends & Yields
This stock pays an annual dividend of 6.10, which amounts to a dividend yield of 1.53%.
| Dividend Per Share | 6.10 |
| Dividend Yield | 1.53% |
| Dividend Growth (YoY) | 8.34% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 25.22% |
| Buyback Yield | 1.90% |
| Shareholder Yield | 3.43% |
| Earnings Yield | 6.83% |
| FCF Yield | 5.20% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |